{7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } Pack

RxCUI: 1491642
RxNorm name: {7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } Pack
Display name: {7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } Pack
Full name: {7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } Pack
Term type: GPCK
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Aptiom	ESLICARBAZEPINE ACETATE	Sumitomo Pharma America, Inc.	3d0c9554-eaeb-4694-8089-00133fcadce3	2023-11-10	Warnings, Adverse reactions	Exact identifier rxcui: 1491642

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
3d0c9554-eaeb-4694-8089-00133fcadce3	{7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } Pack [GPCK] · eslicarbazepine acetate 400 MG (7) / eslicarbazepine acetate 800 MG (7) Pack [PSN] · Titration Sample Pack (7 eslicarbazepine acetate 400 MG Oral Tablet / 7 eslicarbazepine acetate 800 MG Oral Tablet) [SY]	3	16	These highlights do not include all the information needed to use APTIOM safely and effectively. See full prescribing information for APTIOM. APTIOM ® (eslicarbazepine acetate) tablets, for oral use Initial U.S. Approval: 2013	20231110